PharmaMar announces that the Australian Regulatory Agency (TGA) has informed STA that Aplidin (plitidepsin) has been approved for the treatment of multiple myeloma in combination with dexamethasone.
More From BioPortfolio on "PharmaMar receives Australian approval for Aplidin to treat multiple myeloma"